Dr. Bo Jesper Hansen

Dr. Bo Jesper Hansen

Venture Partner

Biography

Bo founded Scandinavian Medical Research, while serving as Medical Advisor for Synthélabo, Pfizer, Inc., Pharmacia Corporation and Yamanouchi Pharmaceutical Co. Ltd. He acted both as Chief Executive Officer and Director of the Board of Swedish Orphan International AB from 1998 to 2010. Dr. Hansen has been with Swedish Orphan International AB since 1993, where he grew the business from a small Nordic-focused niche specialty-/orphan drug pharma to an international organization, with over 60 products across Europe. Prior to joining Swedish Orphan International AB, Bo also co-founded the Shared Clinic "The Prostate Clinic" in Denmark. Most recently, he was Executive Chairman of Swedish Orphan Biovitrum AB and is currently Chairman of the Board of Directors at Karolinska Development AB. Bo is also a director of Orphazyme and Ablynx, Genspera and CMC Contrast (Sweden). He holds an MD and a PhD from the University of Copenhagen. Bo's experience includes orphan drug research and development, international marketing and contract negotiations with extensive knowledge within regulatory, pharmacovigilance, medical marketing and business development with close connections in the Orphan Drug area at executive level. Bo is member of the Company's Audit & Risk Committee and chairman of the Research and Development Committee.